Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570291225566854400
  • NII Article ID
    10019530370
  • Data Source
    • CiNii Articles

Report a problem

Back to top